share_log

SIMPLY BETTER BRANDS CORP. ANNOUNCES YEAR END 2023 FINANCIAL RESULTS

SIMPLY BETTER BRANDS CORP. ANNOUNCES YEAR END 2023 FINANCIAL RESULTS

只是更好的品牌公司公佈 2023 年年底財務業績
PR Newswire ·  04/24 18:00

VANCOUVER, BC, April 24, 2024 /CNW/ - Simply Better Brands Corp. ("SBBC" or the "Company") (TSXV: SBBC) (OTCQB: SBBCF) today reported its audited financial results for the year ended December 31, 2023. All amounts are expressed in United States dollars unless otherwise noted. Certain metrics, including those expressed on an adjusted basis, are non-International Financial Reporting Standards ("IFRS") measures, see "Non-IFRS Measures" below.

不列顛哥倫比亞省溫哥華,2024年4月24日 /CNW/——Simply Better Brands Corp.(“SBBC” 或 “公司”)(多倫多證券交易所股票代碼:SBBC)(場外交易代碼:SBBCF)今天公佈了截至2023年12月31日的年度經審計的財務業績。除非另有說明,所有金額均以美元表示。某些指標,包括調整後表示的指標,是非國際財務報告準則(“IFRS”)的衡量標準,請參閱”非國際財務報告準則指標“下面。

Selected financial and operating information are outlined below and should be read with the Company's consolidated financial statements and related management's discussion and analysis for the year ended December 31, 2023, which are available under the Corporation's profile on SEDAR+ at .

部分財務和運營信息概述如下,應與公司截至2023年12月31日止年度的合併財務報表和相關管理層的討論和分析一起閱讀,這些信息可在SEDAR+的公司簡介下查閱。

SBBC generated revenue of $79.9 million in fiscal 2023, a 22% increase over the prior year, gross profit of $46.9 million, and an adjusted EBITDA loss of $2.7 million. The primary driver of the adjusted EBITDA loss was the performance of the Purekana subsidiary which commenced bankruptcy proceedings earlier this month following completion by SBBC of a comprehensive review of strategic alternatives for the business.

SBBC在2023財年創造了7,990萬美元的收入,比上年增長了22%,毛利爲4,690萬美元,調整後的息稅折舊攤銷前利潤虧損爲270萬美元。調整後的息稅折舊攤銷前利潤虧損的主要驅動因素是Purekana子公司的業績,該子公司在SBC完成了對業務戰略選擇的全面審查後,於本月早些時候啓動了破產程序。

"Our 2023 performance was highlighted by the continued robust growth of TRUBARTM which further expanded its distribution footprint across North America and delivered year over year revenue growth of 133%," said SBBC Interim Chief Executive Officer and Chairman, Kingsley Ward. "With our exit of Purekana now complete, we are putting additional resources and investment behind TRUBARTM and we are well positioned for continued TRUBARTM revenue growth, driving further profit improvement, and debt reduction for SBBC in 2024."

“TRUBAR的持續強勁增長突顯了我們2023年的業績TM 這進一步擴大了其在北美的分銷業務,收入同比增長了133%。” SBC臨時首席執行官兼董事長金斯利·沃德說。“隨着我們對Purekana的退出現已完成,我們正在爲TRUBAR投入更多資源和投資TM 而且我們完全有能力繼續使用 TRUBARTM 收入增長,推動利潤進一步改善,並在2024年減少SBC的債務。”

2023 YEAR KEY COMMERCIAL HIGHLIGHTS

2023 年主要商業亮點

  • TRUBARTM Protein Bar: TRUBARTM revenue was $24.7 million in 2023 compared to $10.6 million in 2022, an increase of $14.1 million. Growth of the brand in 2023 was driven by continued multi-channel distribution expansion to a growing list of major retailers in convenience, grocery, ecommerce and club channels led by Costco.. To support its retail expansion, TRUBARTM signed a strategic agreement with Acosta, a full-service sales agency with deep CPG brand experience and added a second manufacturing facility to its supply chain to meet growing product demand.
  • No B.S. Skincare: Following its online launch and exclusive sale at livenobs.com and Amazon, the No B.S. brand became available at retail in TJ Maxx locations in Q2 2023 followed by a national launch into Walgreen's in Q4 2023 across 3,400 locations.
  • TRUBARTM 蛋白棒: TRUBARTM 2023年的收入爲2470萬美元,而2022年爲1,060萬美元,增長了1,410萬美元。該品牌在2023年的增長是由Costco領導的越來越多的便利店、雜貨店、電子商務和俱樂部渠道主要零售商的多渠道分銷的持續擴張所推動的。爲了支持其零售擴張,TRUBARTM 與擁有深厚CPG品牌經驗的全方位服務銷售機構Acosta簽署了戰略協議,並在其供應鏈中增加了第二個製造工廠,以滿足不斷增長的產品需求。
  • 不是 B.S. 護膚品: 繼在livenobs.com和亞馬遜上線並進行獨家銷售之後,No B.S. 品牌於2023年第二季度在TJ Maxx分店開始零售銷售,隨後於2023年第四季度在沃爾格林的3,400個地點在全國範圍內上市。

FINANCIAL HIGHLIGHTS FOR YEAR ENDED DECEMBER 31, 2023

截至2023年12月31日止年度的財務摘要

For the twelve months ended December 31, 2023, the Company generated revenue of $79.9 million with a gross profit of $46.9 million (59%) compared to $65.4 million with a gross profit of $44.6 million (68%) during the twelve months ended December 31, 2022. Revenue increased by $14.5 million (22% increase) over the prior year's revenues.

在截至2023年12月31日的十二個月中,公司創造了7,990萬美元的收入,毛利爲4,690萬美元(59%),而截至2022年12月31日的十二個月中,公司創造了6,540萬美元的收入,毛利爲4,460萬美元(68%)。收入比上一年的收入增加了1450萬美元(增長22%)。

Operating costs for the twelve months ended December 31, 2023, were $57.6 million, an increase of $3.1 million (6%), compared to $54.3 million for the twelve months ended December 31, 2022.

截至2023年12月31日的十二個月中,運營成本爲5,760萬美元,與截至2022年12月31日的十二個月的5,430萬美元相比,增加了310萬美元(6%)。

During the twelve months ended December 31, 2023, the Company recorded a net loss of $24.3 million compared to a net loss of $12.3 million for the twelve months ended December 31, 2022. Non-cash charges including goodwill impairment, intangible asset impairment, amortization expense and stock-based compensation were $18.1 million. Finance charges accounted for $2.3 million. The impairment charges in 2023 were largely related to the Company's hemp-based businesses and the operating loss was driven by Purekana during 2023. Purekana filed for Chapter 7 bankruptcy on April 3, 2024 after the completion by SBBC of a comprehensive review of strategic alternatives for the business.

在截至2023年12月31日的十二個月中,該公司的淨虧損爲2430萬美元,而截至2022年12月31日的十二個月的淨虧損爲1,230萬美元。包括商譽減值、無形資產減值、攤銷費用和股票薪酬在內的非現金支出爲1,810萬美元。財務費用爲230萬美元。2023年的減值費用主要與公司的大麻類業務有關,2023年的營業虧損是由Purekana推動的。在SBC完成對業務戰略選擇的全面審查後,Purekana於2024年4月3日申請了第7章破產。

For the three months ended December 31, 2023, the Company generated revenue of $12.3 million with a gross profit of $6.7 million (54%) compared to $23.0 million with a gross profit of $16.1 million (70%) during the three months ended December 31, 2022.

在截至2023年12月31日的三個月中,公司創造了1,230萬美元的收入,毛利爲670萬美元(54%),而截至2022年12月31日的三個月中,公司創造了2,300萬美元,毛利爲1,610萬美元(70%)。

Operating costs for the three months ended December 31, 2023, were $10.0 million, a decrease of $9.9 million (50%), compared to $19.9 million for the three months ended December 31, 2022.

截至2023年12月31日的三個月,運營成本爲1,000萬美元,與截至2022年12月31日的三個月的1,990萬美元相比,減少了990萬美元(50%)。

During the three months ended December 31, 2023, the Company recorded a net loss of $14.6 million compared to a net loss of $5.4 million for the three months ended December 31, 2022. Non-cash charges including goodwill impairment, intangible asset impairment, amortization expense and stock-based compensation were $12.9 million. Finance charges accounted for $0.6 million.

在截至2023年12月31日的三個月中,該公司的淨虧損爲1,460萬美元,而截至2022年12月31日的三個月的淨虧損爲540萬美元。包括商譽減值、無形資產減值、攤銷費用和股票薪酬在內的非現金支出爲1,290萬美元。財務費用爲60萬美元。

Non-IFRS Measures (EBITDA and Adjusted EBITDA)

非國際財務報告準則指標(息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤)

EBITDA and Adjusted EBITDA are non-IFRS measures used by management that are not defined by IFRS. EBITDA and Adjusted EBITDA do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures presented by other issuers. Management believes that EBITDA and Adjusted EBITDA provide meaningful and useful financial information as these measures demonstrate the operating performance of the business excluding non-cash charges.

息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤是管理層使用的非國際財務報告準則指標,未由國際財務報告準則定義。息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤不具有國際財務報告準則規定的標準化含義,因此可能無法與其他發行人提出的類似指標相提並論。管理層認爲,息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤提供了有意義和有用的財務信息,因爲這些衡量標準顯示了不包括非現金費用在內的業務經營業績。

"EBITDA" is calculated as earnings before interest, taxes, depreciation, depletion and amortization. "Adjusted EBITDA" is calculated as EBITDA adjusted for non-cash, extraordinary, non-recurring and other items unrelated to the Company's core operating activities.

“息稅折舊攤銷前利潤” 計算爲扣除利息、稅項、折舊、損耗和攤銷前的收益。“調整後息稅折舊攤銷前利潤” 是按扣除與公司核心經營活動無關的非現金、特別、非經常性和其他項目調整後的息稅折舊攤銷前利潤計算得出的。

The most directly comparable measure to EBITDA and Adjusted EBITDA calculated in accordance with IFRS is net loss. The following table presents the EBITDA and Adjusted EBITDA for the twelve months ending December 31, 2023, and 2022, and a reconciliation of same to net income (loss):

與根據國際財務報告準則計算的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤最直接可比的衡量標準是淨虧損。下表列出了截至2023年12月31日和2022年12月31日的十二個月的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤,以及與淨收益(虧損)的對賬情況:


For the years ended




December 31, 2023

December 31, 2022

Change in


$

$

$

%

Net loss

(24.30)

(12.30)

(12.00)

49 %

Amortization

3.80

4.70

(0.90)

(24 %)

Depreciation

-

0.10

(0.10)

100 %

Finance costs

2.30

1.40

0.90

39 %

Income tax recovery

-

(1.00)

1.00

100 %

EBITDA

(18.20)

(7.10)

(11.10)


Acquisition-related costs

-

0.20

(0.20)

100 %

Acquisition costs paid by common shares

-

0.20

(0.20)

100 %

Fair value adjustment of derivative liability

(0.20)

(0.10)

(0.10)

50 %

Impairment of intangible assets

1.00

1.60

(0.60)

(60 %)

Impairment of goodwill

10.90

-

10.90

100 %

Impairment of inventories

0.10

0.20

(0.10)

(100 %)

Impairment of plant and equipment

-

0.20

(0.20)

100 %

Impairment of receivable

0.20

0.10

0.10

50 %

Gain on settlement of the milestone shares

-

(0.40)

0.40

100 %

Share-based payments

2.00

4.30

(2.30)

(115 %)

Consulting fees to be paid by shares

-

0.30

(0.30)

100 %

Shares issued for services

-

0.40

(0.40)

100 %

Warrants issued for services

-

0.10

(0.10)

100 %

Write-off of advance payments

0.30

0.50

(0.20)

(67 %)

Non-recurring expenses

1.20

-

1.20

100 %

Adjusted EBITDA

(2.70)

0.50

(3.20)



在已結束的歲月裏




2023年12月31日

2022年12月31日

變化


$

$

$

%

淨虧損

(24.30)

(12.30)

(12.00)

49%

攤銷

3.80

4.70

(0.90)

(24%)

折舊

-

0.10

(0.10)

100%

財務成本

2.30

1.40

0.90

39%

追回所得稅

-

(1.00)

1.00

100%

EBITDA

(18.20)

(7.10)

(11.10)


與收購相關的成本

-

0.20

(0.20)

100%

普通股支付的收購成本

-

0.20

(0.20)

100%

衍生負債的公允價值調整

(0.20)

(0.10)

(0.10)

50%

無形資產減值

1.00

1.60

(0.60)

(60%)

商譽減值

10.90

-

10.90

100%

庫存減值

0.10

0.20

(0.10)

(100%)

廠房和設備的減值

-

0.20

(0.20)

100%

應收賬款減值

0.20

0.10

0.10

50%

里程碑股份結算收益

-

(0.40)

0.40

100%

基於股份的支付

2.00

4.30

(2.30)

(115%)

諮詢費將通過股票支付

-

0.30

(0.30)

100%

爲服務而發行的股票

-

0.40

(0.40)

100%

爲服務發行的認股權證

-

0.10

(0.10)

100%

註銷預付款

0.30

0.50

(0.20)

(67%)

非經常性費用

1.20

-

1.20

100%

調整後 EBITDA

(2.70)

0.50

(3.20)


The Company had an Adjusted EBITDA loss of $2.7 million for the twelve months ending December 31, 2023, a decrease of $3.2 million over the Adjusted EBITDA of $0.5 million for the comparable period in 2022. The primary driver for the increased Adjusted EBITDA loss of $2.7 million for the twelve months ending December 31, 2023, is the increase in cash operating expenses ($6.2 million) which were offset by increased gross profits ($2.3 million) and non-recurring expenses ($1.2 million) compared to the prior period in 2022. The biggest contributor to the Adjusted EBITDA loss was Purekana for the twelve months ended December 31, 2023. On a stand-alone basis, Purekana was the biggest driver of the EBITDA loss before non-recurring expenses. Purekana's 2023 EBITDA loss was $4.1 million compared to TRU's positive EBITDA of $1.0 million during the year. The other divisions did not contribute materially to the Adjusted EBITDA loss for the year. Purekana filed for Chapter 7 bankruptcy on April 3, 2024 after the Company's Board had explored all viable options for this business.

截至2023年12月31日的十二個月中,該公司的調整後息稅折舊攤銷前利潤虧損爲270萬美元,比2022年同期的50萬美元調整後息稅折舊攤銷前利潤減少了320萬美元。截至2023年12月31日的十二個月中,調整後息稅折舊攤銷前利潤虧損增加270萬美元的主要驅動因素是現金運營支出(620萬美元)的增加,但與2022年前期相比,毛利潤(230萬美元)和非經常性支出(120萬美元)的增加抵消了這一增長。截至2023年12月31日的十二個月中,調整後息稅折舊攤銷前利潤虧損的最大貢獻者是Purekana。單獨來看,Purekana是扣除非經常性支出前的息稅折舊攤銷前利潤虧損的最大驅動力。Purekana2023年的息稅折舊攤銷前利潤虧損爲410萬美元,而TRU同年的息稅折舊攤銷前利潤爲100萬美元。其他部門沒有對該年度調整後的息稅折舊攤銷前利潤虧損產生重大影響。在公司董事會探索了該業務的所有可行選擇之後,Purekana於2024年4月3日申請了第7章破產。

The most directly comparable measure to EBITDA and Adjusted EBITDA calculated in accordance with IFRS is net loss. The following table presents the EBITDA and Adjusted EBITDA for the three months ended December 31, 2023, and 2022, and a reconciliation of same to net income (loss):

與根據國際財務報告準則計算的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤最直接可比的衡量標準是淨虧損。下表列出了截至2023年12月31日和2022年12月31日的三個月的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤,以及與淨收益(虧損)的對賬情況:


For the three months ended




December 31, 2023

December 31, 2022

Change in


$

$

$

%

Net loss

(14.60)

(5.40)

(9.20)

63 %

Amortization

0.70

3.30

(2.60)

(371 %)

Finance costs

0.60

0.50

0.10

17 %

Income tax recovery

-

(1.00)

1.00

100 %

EBITDA

(13.30)

(2.60)

(10.70)


Fair value adjustment of derivative liability

(0.10)

-

(0.10)

100 %

Impairment of intangible assets

0.80

1.60

(0.80)

(100 %)

Impairment of goodwill

10.90

-

10.90

100 %

Impairment of inventories

(0.10)

0.20

(0.30)

300 %

Impairment of plant and equipment

-

0.20

(0.20)

100 %

Share-based payments

0.40

0.80

(0.40)

(100 %)

Consulting fees to be paid by shares

-

0.30

(0.30)

100 %

Shares issued for services

-

(0.10)

0.10

100 %

Warrants issued for services

-

0.10

(0.10)

100 %

Write-off of advance payments

0.20

0.10

0.10

50 %

Non-recurring expenses

0.40

-

0.40

100 %

Adjusted EBITDA

(0.80)

0.60

(1.40)



在結束的三個月裏




2023年12月31日

2022年12月31日

變化


$

$

$

%

淨虧損

(14.60)

(5.40)

(9.20)

63%

攤銷

0.70

3.30

(2.60)

(371%)

財務成本

0.60

0.50

0.10

17%

追回所得稅

-

(1.00)

1.00

100%

EBITDA

(13.30)

(2.60)

(10.70)


衍生負債的公允價值調整

(0.10)

-

(0.10)

100%

無形資產減值

0.80

1.60

(0.80)

(100%)

商譽減值

10.90

-

10.90

100%

庫存減值

(0.10)

0.20

(0.30)

300%

廠房和設備的減值

-

0.20

(0.20)

100%

基於股份的支付

0.40

0.80

(0.40)

(100%)

諮詢費將通過股票支付

-

0.30

(0.30)

100%

爲服務而發行的股票

-

(0.10)

0.10

100%

爲服務發行的認股權證

-

0.10

(0.10)

100%

註銷預付款

0.20

0.10

0.10

50%

非經常性費用

0.40

-

0.40

100%

調整後 EBITDA

(0.80)

0.60

(1.40)


The Company had an Adjusted EBITDA loss of $0.8 million for the three months ended December 31, 2023, a $1.4 million reduction over the Adjusted EBITDA achieved in the comparable period in 2022. The reduction in Adjusted EBITDA was due to the lower sales and gross profit in the fourth quarter of 2023 compared to the prior year's sales and gross profit.

截至2023年12月31日的三個月,該公司調整後的息稅折舊攤銷前利潤虧損80萬美元,比2022年同期的調整後息稅折舊攤銷前利潤減少了140萬美元。調整後息稅折舊攤銷前利潤的減少是由於2023年第四季度的銷售額和毛利與上一年的銷售額和毛利相比有所下降。

Readers are cautioned that EBITDA and Adjusted EBITDA should not be construed as an alternative to net income as determined under IFRS; nor as an indicator of financial performance as determined by IFRS; nor a calculation of cash flow from operating activities as determined under IFRS; nor as a measure of liquidity and cash flow under IFRS. The Company's method of calculating EBITDA and Adjusted EBITDA may differ from methods used by other companies and, accordingly, the Company's EBITDA and Adjusted EBITDA may not be comparable to similar measures used by any other company. Except as otherwise indicated, EBITDA and Adjusted EBITDA are calculated and disclosed by SBBC on a consistent basis from period to period. Specific adjusting items may only be relevant in certain periods.

提醒讀者,不應將息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤解釋爲國際財務報告準則確定的淨收益的替代方案;也不應解釋爲國際財務報告準則確定的財務業績指標;也不應解釋爲根據國際財務報告準則確定的經營活動現金流的計算;也不應解釋爲衡量國際財務報告準則下流動性和現金流的指標。公司計算息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤的方法可能與其他公司使用的方法不同,因此,公司的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤可能無法與任何其他公司使用的類似指標進行比較。除非另有說明,否則息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤由SBC在不同時期持續計算和披露。特定的調整項目可能僅在特定時期有效。

See also Earnings before Interest, Taxes, Depreciation, and Amortization ("EBITDA") and Adjusted EBITDA (Non-GAAP Measures) in the Company's management discussion and analysis for the year ended December 31, 2023 available on SEDAR+ at .

另請參閱截至2023年12月31日的公司管理層討論和分析中的扣除利息、稅項、折舊和攤銷前的收益(“息稅折舊攤銷前利潤”)和調整後的息稅折舊攤銷前利潤(非公認會計准則指標),可在SEDAR+上查閱。

Liquidity and Capital Resources

流動性和資本資源

The Company's primary liquidity and capital requirements are for inventory and general corporate working capital purposes. The Company had a cash balance of $2.3 million as of December 31, 2023, which will provide capital to support the planned growth of the business and for general corporate working capital purposes. The Company's working capital deficiency increased from $9.3 million as of December 31, 2022, to a working capital deficiency of $12.4 million as of December 31, 2023 ($3.1 million increase). Working capital deficiency included the Mainstreet loan ($10.4 million) which is classified as current whereas the term of the loan is maturing in December 2025. The Mainstreet loan has a five-year term with principal repayments due to start in December 2023 with the first $1.5 million principal repayment. Purekana was in discussions with the financial institution to restructure that Mainstreet loan payment into several installments to be paid in 2024 at year-end. This loan has several covenants including annual and quarterly reporting and debt service coverage. It has been classified as current as a result of the noncompliance with the debt service covenant. Also see subsequent events in the financial statements concerning the status of the Company's Purekana subsidiary and the Mainstreet loan (Purekana, LLC filed for Chapter 7 bankruptcy on April 3, 2024). The bankruptcy of Purekana will remove Purekana's $10.4 Million loan obligation from SBBC's consolidated financial statements.

公司的主要流動性和資本要求用於庫存和一般公司營運資金的目的。截至2023年12月31日,該公司的現金餘額爲230萬美元,這將爲支持業務的計劃增長和一般公司營運資本提供資金。該公司的營運資金赤字從截至2022年12月31日的930萬美元增加到截至2023年12月31日的1,240萬澳元的營運資金赤字(增加310萬美元)。營運資金短缺包括Mainstreet貸款(1,040萬美元),該貸款被歸類爲流動貸款,而貸款期限將於2025年12月到期。Mainstreet貸款的期限爲五年,本金還款將於2023年12月開始,首期還款額爲150萬美元。Purekana正在與該金融機構討論將Mainstreet貸款的還款重組爲分期付款,將於2024年年底支付。這筆貸款有多個契約,包括年度和季度報告以及還本付息保險。由於不遵守還本付息協議,它被歸類爲最新債務。另見財務報表中有關公司Purekana子公司狀況和Mainstreet貸款的後續事件(Purekana, LLC於2024年4月3日申請第7章破產)。Purekana的破產將從SBC的合併財務報表中刪除Purekana的1,040萬美元貸款義務。

The Company continues to focus on improving its working capital position through a number of initiatives including equity and convertible debt private placements, issuance of promissory notes and establishment of lines of credit for its subsidiaries.

公司繼續專注於通過多項舉措改善其營運資金狀況,包括股權和可轉換債務私募配售、發行期票和爲子公司設立信貸額度。

Private Placements

私募配售

In February 2023, the Company completed a private placement of units for CAD $7 million in equity to be used for further debt reduction, working capital and for growth initiatives in 2023.

2023年2月,公司完成了700萬加元股權單位的私募配售,用於進一步減債、營運資金和2023年的增長計劃。

The Company also announced on April 17, 2024 a non-brokered private placement of up to 5,714,285 units of the Company (the "Units") at a price of $0.35 per Unit, for aggregate gross proceeds of up to $2,000,000. Each Unit will consist of one (1) common share in the capital of the Company (each, a "Share") and one-half of one Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one (1) additional Share at an exercise price of $0.45 per Share for a period of 24 months following the closing of the non-brokered private placement.

該公司還於2024年4月17日宣佈,以每單位0.35美元的價格進行公司多達5,714,285個單位(“單位”)的非經紀私募配售,總收益高達200萬美元。每個單位將由公司資本中的一(1)股普通股(每股 “股份”)和一半的股票購買權證(每份完整認股權證,一份 “認股權證”)組成。每份認股權證的持有人將有權在非經紀私募配售結束後的24個月內以每股0.45美元的行使價額外購買一(1)股股票。

Convertible Debentures

可轉換債券

The Company paid down $1.7 million in convertible debentures including accrued interest that were due in February 2023.

該公司償還了170萬澳元的可轉換債券,包括2023年2月到期的應計利息。

Line of Credit Facilities

信貸額度

Additionally, the Company has secured several lines of credit facilities for three of its subsidiaries to support the financing of purchase orders from key customers. These lines of credit have been critical to finance the large retail purchase orders the Company's subsidiaries have successfully generated during the twelve months ended December 31, 2023. For more information of the line of credit facilities please refer to note 10 in the audited financial statements for the year ended December 31, 2023. During the twelve months ended December 31, 2023, the Company raised over $18.1 million in funds from these lines of credit to finance purchase orders from its large retail customers. Over the same period, the Company repaid over $16.1 million of these credit facilities to the lender. TRU was able to increase its primary line of credit with this lender to $6 million in December 2022. The nature of these loans is to turnover between 3-5 months from the time the money is advanced to repayment.

此外,該公司還爲其三家子公司獲得了多筆信貸額度,以支持主要客戶的採購訂單融資。這些信貸額度對於爲公司子公司在截至2023年12月31日的十二個月中成功生成的大額零售採購訂單提供資金至關重要。有關信貸額度的更多信息,請參閱截至2023年12月31日的年度經審計的財務報表附註10。在截至2023年12月31日的十二個月中,公司從這些信貸額度中籌集了超過1,810萬美元的資金,爲其大型零售客戶的採購訂單提供資金。同期,公司向貸款機構償還了超過1,610萬美元的信貸額度。2022年12月,TRU得以將其向該貸款機構提供的主要信貸額度增加到600萬美元。這些貸款的性質是從預付資金到還款的3-5個月之間週轉。

Promissory Notes

本票

During the three months ended December 31, 2023, the Company reduced the balance of promissory notes outstanding by approximately $1.0 million (see note 13 in the financial statements for the year ended December 31, 2023). All promissory notes paid off during the year had a maturity less than 12 months. The balance of promissory notes was $2.4 million as of December 31, 2022, and the balance as of December 31, 2023, is $1.45 million.

在截至2023年12月31日的三個月中,公司將未償還的期票餘額減少了約100萬美元(見截至2023年12月31日的年度財務報表附註13)。年內還清的所有期票的到期日均小於12個月。截至2022年12月31日,期票餘額爲240萬美元,截至2023年12月31日的餘額爲145萬美元。

The Company's ability to fund operating expenses will depend on its future operating performance which will be affected by general economic, financial, regulatory, and other factors including factors beyond the Company's control (See "Risk and Uncertainties").

公司爲運營費用提供資金的能力將取決於其未來的經營業績,這將受到總體經濟、金融、監管和其他因素的影響,包括公司無法控制的因素(見 “風險和不確定性”)。

Management continually assesses liquidity in terms of the ability to generate sufficient cash flow to fund the business. Net cash flow is affected by the following items: (i) operating activities, including the level of accounts receivable, other receivable, accounts payable, accrued liabilities and unearned revenue and deposits; (ii) investing activities (iii) financing activities.

管理層不斷根據產生足夠現金流爲業務提供資金的能力來評估流動性。淨現金流受以下項目影響:(i) 經營活動,包括應收賬款、其他應收賬款、應付賬款、應計負債和未得收入和存款的水平;(ii) 投資活動 (iii) 融資活動。

About Simply Better Brands Corp.

關於Simply Better品牌公司

Simply Better Brands Corp. is an international omni-channel platform with a portfolio of diversified assets in the rapidly growing plant-based, natural, and clean ingredient space. The Company targets informed, health conscious Millennial and Generation Z consumers with a focus opportunities for expansion into high-growth consumer product categories. For more information on Simply Better Brands Corp., please visit: For more information on Simply Better Brands Corp., please visit:

Simply Better Brands Corp. 是一個國際全渠道平台,在快速增長的植物性、天然和清潔成分領域擁有多元化資產組合。該公司以知情、注重健康的千禧一代和Z世代消費者爲目標,重點關注向高增長消費品類別擴張的機會。有關 Simply Better Brands Corp. 的更多信息,請訪問:有關 Simply Better Brands Corp. 的更多信息,請訪問:

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward-Looking Information

前瞻性信息

Certain statements contained in this news release constitute "forward-looking information" and "forward looking statements" as such terms are used in applicable Canadian securities laws. Forward-looking statements and information are based on plans, expectations and estimates of management at the date the information is provided and are subject to certain factors and assumptions, including, among others, that the Company's financial condition and development plans do not change as a result of unforeseen events, the regulatory climate in which the Company operates, and the Company's ability to execute on its business plans. Specifically, this news release contains forward-looking statements relating to, but not limited to: expansion plans for TRU Brands products, and success of the Company's marketing efforts.

本新聞稿中包含的某些陳述構成 “前瞻性信息” 和 “前瞻性陳述”,因爲這些術語在適用的加拿大證券法中使用。前瞻性陳述和信息基於管理層在提供信息之日的計劃、預期和估計,並受某些因素和假設的約束,包括公司的財務狀況和發展計劃不會因不可預見的事件、公司運營的監管環境以及公司執行業務計劃的能力而發生變化。具體而言,本新聞稿包含與但不限於TRU Brands產品的擴張計劃以及公司營銷工作的成功相關的前瞻性陳述。

Forward-looking statements and information are subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking statements and information. Factors that could cause the forward-looking statements and information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, ability to obtain necessary regulatory approvals for proposed transactions, as well as the other risks and uncertainties applicable to the plant-based food, clean ingredient skincare and plant-based wellness or broader wellness industries and to the Company, and as set forth in the Company's management's discussion and analysis available under the Company's SEDAR+ profile at .

前瞻性陳述和信息受各種風險和不確定性以及其他因素的影響,這些因素可能導致計劃、估計和實際結果與此類前瞻性陳述和信息中的預測存在重大差異。可能導致本新聞稿中的前瞻性陳述和信息發生變化或不準確的因素包括但不限於所提及的任何假設被證明無效或不可靠的風險、上述事件發生並導致計劃工作延遲或停止的風險、公司的財務狀況和發展計劃發生變化、擬議交易獲得必要監管部門批准的能力以及其他風險以及適用於工廠的不確定性-基於食品、清潔成分的護膚品和植物性健康或更廣泛的健康行業以及公司管理層的討論和分析中所述,可在公司的SEDAR+簡介中查閱。

The above summary of assumptions and risks related to forward-looking statements in this news release has been provided in order to provide shareholders and potential investors with a more complete perspective on the Company's current and future operations and such information may not be appropriate for other purposes. There is no representation by the Company that actual results achieved will be the same in whole or in part as those referenced in the forward-looking statements and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities law.

本新聞稿中提供上述與前瞻性陳述相關的假設和風險摘要是爲了讓股東和潛在投資者更全面地了解公司當前和未來的業務,此類信息可能不適用於其他目的。除非適用的證券法另有要求,否則公司沒有聲明所取得的實際業績將與前瞻性陳述中提及的全部或部分相同,並且公司不承擔任何義務公開更新或修改所包含的任何前瞻性陳述,無論是由於新信息、未來事件還是其他原因。

SOURCE Simply Better Brands Corp.

消息來源 Simply Better

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論